Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDLexicon Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.05 | -$0.03 | -$0.03 |
| Q2 2026 | 3 | -$0.05 | -$0.04 | -$0.05 |
| Q3 2026 | 3 | -$0.07 | -$0.05 | -$0.06 |
| Q4 2026 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q2 2027 | 1 | -$0.06 | -$0.06 | -$0.06 |
| Q3 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q4 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
Lexicon Pharmaceuticals Inc Earnings Date And Information
Lexicon Pharmaceuticals Inc last posted its earnings results on Thursday, May 7th, 2026. The company reported $-0.0026 earnings per share for the quarter, topping analysts' consensus estimates of $-0.04 by $0.0374. The company had revenue of 21.10 M for the quarter and had revenue of 49.80 M for the year. Lexicon Pharmaceuticals Inc has generated $0 earnings per share over the last year ($-0.14 diluted earnings per share) and currently has a price-to-earnings ratio of -30.11. Lexicon Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Lexicon Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/07/2026 | Q1 2026 | -$0.04 | -$0.00 | 0.04 | $9.79 M | $21.10 M |
| 03/05/2026 | Q4 2025 | -$0.07 | -$0.04 | 0.03 | $3.14 M | $5.49 M |
| 11/06/2025 | Q3 2025 | -$0.07 | -$0.04 | 0.03 | $4.65 M | $14.18 M |
| 08/06/2025 | Q2 2025 | -$0.08 | $0.01 | 0.09 | $4.87 M | $28.87 M |
| 05/14/2025 | Q1 2025 | N/A | -$0.07 | N/A | $1.41 M | $1.26 M |
| 03/07/2025 | Q4 2024 | N/A | -$0.09 | N/A | $6.48 M | $26.55 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.18 | N/A | $2.99 M | $1.75 M |
| 08/02/2024 | Q2 2024 | N/A | -$0.17 | N/A | $3.44 M | $1.65 M |
| 05/02/2024 | Q1 2024 | -$0.18 | -$0.20 | -0.02 | $1.40 M | $1.13 M |
| 03/25/2024 | Q4 2023 | N/A | -$0.20 | N/A | N/A | $702.00 K |
| 11/08/2023 | Q3 2023 | -$0.22 | -$0.21 | 0.01 | N/A | $162.00 K |
| 08/04/2023 | Q2 2023 | N/A | -$0.22 | N/A | N/A | $317.00 K |
| 05/04/2023 | Q1 2023 | N/A | -$0.16 | N/A | N/A | $24.00 K |
| 03/03/2023 | Q4 2022 | N/A | -$0.16 | N/A | N/A | $28.00 K |
| 11/09/2022 | Q3 2022 | -$0.15 | -$0.14 | 0.01 | N/A | $39.00 K |
| 08/03/2022 | Q2 2022 | N/A | -$0.17 | N/A | N/A | $35.00 K |
| 05/05/2022 | Q1 2022 | -$0.16 | -$0.16 | 0 | N/A | $37.00 K |
| 03/10/2022 | Q4 2021 | N/A | -$0.17 | N/A | N/A | $14.00 K |
| 11/09/2021 | Q3 2021 | N/A | -$0.16 | N/A | N/A | $23.00 K |
| 08/06/2021 | Q2 2021 | N/A | -$0.13 | N/A | N/A | $234.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lexicon Pharmaceuticals Inc Earnings: FAQ's
In the previous quarter, Lexicon Pharmaceuticals Inc (:LXRX) reported $-0.0026 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.04 by $0.0374.
The conference call for Lexicon Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for Lexicon Pharmaceuticals Inc's latest earnings report can be read online.
Lexicon Pharmaceuticals Inc (:LXRX) has a recorded annual revenue of $49.80 M.
Lexicon Pharmaceuticals Inc (:LXRX) has a recorded net income of $-50,341,000.Lexicon Pharmaceuticals Inc has generated $-0.14 earnings per share over the last four quarters.
Lexicon Pharmaceuticals Inc (:LXRX) has a price-to-earnings ratio of -30.11 and price/earnings-to-growth ratio is -0.11.